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CNP in early asymptomatic left ventricular dysfunction (ALVD, NYHA 1)are
undefined. The preeent study investigated the releaee of cardiac ANP, BNP
and CNP in human CHF and determined releaae in ALVD as compared to
symptomatic CHF (NYHA II and Ill). Twenty-two patients (NYHA I to Ill) with
dilated or ischemic cardiomyopathy were studied. Plasma ANP, BNP and
CNP were determined in blood samples from the anterior intetventricular
vein (AIV), the coronary sinus (CS) and the aortic root (Ao) by radioim-
munoessay (Phoenix, Mountain View, CA) in which the difference between
Ao and CS indicates total cardiac release and the difference between Ao
and AIV indicates ventricular release. Cardiac ANP, BNP and CNP release
in ALVD (NYHA Class 1)and symptomatic heart failure (NYHA Class II and
111)are reported below: *p< 0.05 vs Ao.
Ao AIV Cs
NYHA I (n =7)
ANP (pglml) 145 &74 440 + 155* 500 + 152”
BNP (pg/ml) 29& S 30• 9 38& 2
CNP (p@ml) 14+2 13+2 12*2
NYHA 11-111(n = 15)
ANP (p@’ml) ‘ 267 + 100 554 + 159” 524 + 114”
BNP (pg/ml) 53* 12 130 + 27* 10s + 19*
CNP (p@ml) 13+2 14*3 13+2
These data demonstrate: (1) in ALVD, selective ventricular release of
ANP occurs. (2) In symptomatic CHF, ventricular relaasa of ANP and BNP
is significant and (3) CNP is not secreted from the heart in human CHF. In
conclusion, these studies support an important role for ventricular secretion
of ANP and BNP in severe human CHF and differential ventricular secretion
of ANP and BNP in ALVD.
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1783-31Nocturn~lM~l~~onin~~,~~*,~P~ir~~nt~n~
Clinical Effecta of Exoganous Melatonin in Chronic
Heart Failure
F.S.Malik, M.R. Mehra, A. Ali, H.O. Ventura, D.D. Stapleton, P.Brugger,
F.W.Smart. Ochsner Medical Institutions, New Orfeans, LA, USA
Qualitative sleep abnormalities are frequently reported by chronic heart fail-
ure (HF) patients. Melatonin (M), a nocturnally released hormone from the
pineal gland, has been implicated in sleep mediation. In this two-part study,
we first sought to determine abnormalities in circadian M release in chronic
HF by measuring serum M levels in 11 HF patiante (NYHA H; EF <0.2,
without concurrent hepato-renal disease), with complaints of insomnia, and
comparad the levels with age and sex-matched normal controls (n = 11), In
the second part, we studied the effect of nocturnal M replacement (3 mg)
in 6 advanced HF patients (NYHA IV; EF < 0.2) with sleep disturbances
by administering either placebo or melatonin for 4 nights in a double blind,
randomized cross-over study design. Serum for M was drawn et 020+3,0500,
and 141X hours under controlled light and temperature environment. The
patient’s response to intervention was assessed by a modified sleep ques-
tionnaire. Reauks: M levels were significantly suppressed at 0200 and 0500
hours in HF patients comparecfto controls. Mwas undetectable in all daytime
aamplee.
Heart Failure Controls P Value
Melatonin(p@ml) 9.5 * 5.3 37.3 i 5.3 <0.01
Nocturnal replacement in 5 of 6 study patients was associated with sig-
nificant improvement in sleep duration and quality of sleep.
Placsbo Melatonin P
Tme to onset of sleep (rein) 90* 15 30+ 15 <0.05
Durationof sleep (hours) 2*1 5&2 <0,05
Episodesof awakeninghight 3*1 1*1 ns
~me to sleep after awake (rein) 120 l 40 30* 15 <0,05
Two patients reported minor fogginess the day after melatonin. /nfer-
ences: Sleep abnormalities in chronic HF are accompanied by impairment
in the nocturnal release of endogenous melatonin. Furthermore, exogenous
replacement of nightime melatonin improves sleep patferns in severe chronic
heart failure.
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783-4 Effect of Adenosine on the Renal Circulation in
Patients with Chronic Heart Failure
A. Mehra, G. ,Cohen,J.V. Johnson, U. Elkayam. USC School of Medicine,
Los Angelas, CA, USA
Adenosine is produced in the kidney and plays a role in renal vasoregulation
via stimulation of adenosine receptors. However, the effect of exogenous
adenosine on the renal circulation in humans is not well defined. Because of
its potential therapeutic role, we studied the renal circulatory effect of axoge-
nous adenosine in 9 pts with chronic heart failure (CHF) undergoing cardiac
catheterization. Adenosine was infused directly into the renal artery at a dose
calculated to achieve a blood concentration of 10-8 to 10-4M. Main renal
artery cross sectional area (CSA) was measured by intravascular ultrasound
and renal blood flow velocity by intravascular Doppler. Flow velocity integral
(FVI) was measured by planimet~ and renal blood flow was calculated by
the following formula: Heart rate x CSA x FVI. Effect of adenosine was as
follows:
Mean BP (mmHg) CSA (cm2) VT (m) Ranal BloodFlow (mlJmin)
Basalins 91 & 10 0.391 + 0.123 26+ 16 766+ 324
Adenosine 91 + 12 0,3s1 * 0.104 10* s 296 + 144
P Value 0.s 0.3 <0.002 <0.001
Although no change was noted in mean blood pressure (BP) and renal
artery CSA, there was a significant fall in Doppler FVI and renal blood flow.
Conclusion: Adenosine does not have an affect on large (conductance)
renal arIeries but has a marked vasoconstrictive effect on small (resistance)
arteries which leads to a severe reduction in RBF.
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~] lsitSafatoprescribe AaPirinto patienteon
ACE-lnhibitors?
J. Leer, H. Reicher-Reiss, U. Goldbourf, A. Shotan, V. Boyko, S. Gottlieb,
A. Baltler, S. Behar. Cardiology Division, Ben Gurion University Beer
Sheva, keel, Neufeld Cardiac Research Institute, TelHashomec Israel
Several provocative reports have recently suggested that aspirin has dele-
terious interaction with ACE-inhibitors and might attenuate their beneficial
effects upon survival in pts with congestive heart failure (CHF) or coronary
artery disease (CAD). To addrass this issue we analyzed mortality date of
11,575patients with CAD screened for the Bezafibrate Infarction Prevention
(BIP) trial. 1247 pts (11%) were treated with ACE-inhibitors. Of them, 666
pte (54%) used aspirin (ASA+) and 579 did not (ASA–). Both groups were
similar with respect to age, history of diabetes, hypertension, smoking, CHF
and stroke. Female gender, history of Ml and angina were more frequent in
ASA (+) pts. Mortality (4.2 yrs) was lower among ASA (+) pts than ASA (-)
pts (14% vs. 23%; p < 0.001). In multivariate analysis, the use of ASA in pts
on ACE- inhibitore was associated with Iowermonality risk [(relative risk (RR)
0.57; 95% confidence interval (Cl) 0.35-0.93]. Subgroup analysis of 479 pts
with CHF (NYHA class ?2) treated with ACE-inhibitors, revealed 236 ASA
(+) pts and 243 ASA (–) pts. Although clinical characteristics and therapies
were similar, ASA (+) pts experienced lower mortality than ASA (–) pts (17%
vs. 32%; p = 0.001). In multivafiate analysis, administration of ASA was
still associated with lower morfality but with borderline significance [RR-O.61
(0.29-1.28)]. Conclusions: In pts with coronary artery disease, addition of
aspirin to ACE-inhibitors was associated with lower mortality. There was no
excess mortality in subgroup of hearI failure pts treated with ACE-inhibitors
and aspirin. Our findings contradict the claim that aspirin has antagonistic
interaction with ACE-inhibitors.
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~] Massive Fluid Acc.mu,ationD~es NotAffectthe
Pharmacokinetics of the Loop Diuretics Furoaemlde
and Torsemide in Patients With Heart Failure
S.S. Gottlieb, M. Khatfa, D. Wentworth, DS. Roffman, M.L. Fisher,
W. Kramer. Univarsify of Maryland Schools of Medicine and Pharmacy,
Baltimore, MD, USA
Intravenous diuretics are thought to be required in decompensated heart
failure (CHF) because of presumed bowel edema which decraasas or delays
drug absorption. However,oral loop diuretic pharmacokinetics have not been
studied in CHF patients (pts) prior to and after change in fluid status. We
therefore evaluated 37 massively fluid overloaded CHF pts randomized to
receive either furosemide (Fur, 127 t 104 mg) or torsemide (Tor, 65 + 40
mg). There were 26 men & 11women, mean age of 60 (range 35 to 60). All
pts were studied before (Pre) and after (Post) diuresis to euvolemia (at least
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15 Ibs). We measured relative bioavailability by area under the cutve (AUC,
hrx&g/ml), peak concentration (Cmex, &g/ml), time to peak concentration
(Tmex, hr), renal clearance (Clr, ml/min), & weight (wt, Ibs), where *p <0.05
v. Pre:
Drug lime AUC Cmax Tmax Clr Wt
Fur Pre 14.4 + 12.5 3.1 l1.5 2.05 + 0.94 44 +24 220*28
Fur Post 18.7 +21 3.9 * 2.0 2.09+ 1.87 45+ 24 200+28”
Tor Pre 44.8 + 20.36 10.9+ 50.1 1.40+ 0.82 6.4 +3.9 212 +46
Tor Post 46.3 & 22.2 13.9 + 6.7* 0.81 + 0.36* 6.4 +3.5 190+44;
Wtdecreased 21 Ibs(range 15t053). Incontrasttothe expecfedoutcome,
intense diuresis had minimal effect on absorption and no effect on renal
clearance. With diuresis, AUC increased by >30% in only 2/33 pts and
Cmex increased by sYYYo in only 10/34 pts. There were no differences
between Fur and Tor in the effects of edema on pharrnacokinetics.
We conclude that bowel edema secondary to fluid overload does not
alter the pharmacokinetics of Fur or Tor in most CHF pts. Therefore, oral
bop diuretics may be effective in decompensated CHF pts and their use in
adequate dosea may save money and reduce hospitalizations.
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784-1 Thres Dimensional Flow Reconstruction of Irregular
Stenotic Mltrel Bioprostheses: In Vitroand Animal
Studies
R.Shandas, M. Jones, M. Chikada, J. Kwon, O. Knudson, L. Valdea-Cruz.
The Children’s Hospitsl, Denvec CO, LAMS-NHLBL Bethesda, MD, USA
Calculation of effective orifice areas for flow through irregularly shaped, mod-
erately stenosed mitral bioprostheses has been problematic using current
Doppler or catheter methods since the complexity of the orifice obviates
many of the assumptions used in these techniques. Three-dimensional (3D)
flow reconstruction of two-dimensional (2D) color Doppler images should
provide complete transvalvular flow information and thereby allow estimation
of irregular orifice areas. 3D flow reconstruction was performed on color
Doppler images of forward flow through 4 moderately stenosed (1.65-2.88
Cmz) bioproatheses p&,edina pulsatile in vitro SySteM(4~0 c~beat; 80
bpm). Additionally, 3D flow images were also obtained from 2 sheep with
bioproathetic mitral valves. Effective flow areas were obtained aa the min-
imum cross-sectional flow area of the 3D flow image immediately distal to
the orifice. Anatomic valve areas were measured by video planimeby pest
explantstion. Irregular and asymmetric orifices due to incomplete opening of
the stenotic leaflets were visualized well on the 3D flow images. 3D effective
orifice areas for both in vitro and animal studies correlated well to anatomic
areas but with overestimation (y = 1.98x – 0.58; R = 0.928; SEE = 0.28
cm2) Thi$ overestimation is presumably due to the poor lateral resolution
of the color Doppler system which cannot distinguish between jet core flow
and adjacent entrainment flow. Such errors become compounded in 3D re-
constructions due to the integration of all 2D flow information. 3D provides
advantages over 2D color Doppler in displaying the irregular and asymmetric
orifice shapes of moderately stenosed mitral bioprostheses. 3D also offers
more accurate localization of the effective orifice (vena corrtrecta)area than
2D or mlor Doppler and so should be useful in the clinical assessment of
bioprosthetic valves.
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Verying Morphology of Mitrsl Valve Commissures,
Commissursl Fusion snd Orifice in Mitral Stenosis,
Mitral Regurgitation and Combined Lesions in
Rheumatic Valve Disssse: A Three-Dimensionsl
Echocsrdiogrephic Study
R. Kasliwal, A. Kanojia, S. Mittal, N. Masani, T.-L. Hsu, N. Trehan,
N. Pandian. Escorts Hearf Institute and Resesrch Centec New Delhi, India,
Tufts-New England Medical Centec Boston, MA, USA
The extent of commis8ural fusion (CF) is a determinant of therapeutic options
but may be difficult to assess using conventional imaging techniques. The
purpose of this study was to determine whether three-dimensional echocar-
diography (3DE) could be used tovisualizethe mitral commissuresand orifice
to assessCF in various forms of rheumatic mitral valve disease (RMVD).
3DE was performed in 54 pts with RMVD undergoing TEE. In 45 pts (83%)
it was possible to create en face 3D images of the mitral valve viewed from
above, allowing visualization of the left atrial aspect of tha mitral Ieafleta, line
of coeptetion and orifice. CF was assessed in 2 waya: shape of the orifice at
the commissures (either round or angulated) and appearance of the line of
coaptation, whereby O = no visible coaptation Iina (dense CF), 1 = “gutter”
visible (moderate CF), 2 = coaptation line clearty visible (miicf/no CF). The
eccentricity of the orifice was also assessed and the distance between orifice
and annulus measured. The 3DE data was compared with the clinical pre-
sentation of each pt. The number of commissures ciaseified in each group is
shown in the table:
P%(n) Orifice Coaptationline
round angular 012 mean score
MS 30 24 36 37 21 2 0.41
MSIMR 9 8 10 12 4 2 0.44
MR 6 0 12 1 1 10 1.75
With MS the orifice was central in 20 pts and eccentric in 10, whereas
the orifice was central in 8/9 pts with MS/MR and 8/8 pts with MR. Thus,
MS wee characterized by more rounded orifices and dense fusion while in
MR angular orifices with minimal CF were seen. 3DE provides new insights
into dynamic pathology and pathophysiology of the mitral valve in RMVD that
have therapeutic implications.
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PI The FessibiliW$ndln~rementsl Vslueof
Thrse-Dimensional Intrsoperstive TEE in Valve
surgery: A Prospective Study in 40 Consecutive
Pstients
S.Ge,J.G. Warner, Jr., T.P.Abraham, N.D. Ken, A.M. Nomeir, K. Fowle,
R.F.Brooker, D.W. Kifzman. Bowman Gray School of Medicine of Wake
Forest University Winston-Salem, NC, USA
Three-dimensional echocardiography (3DE) has the potential to provide su-
periorquality morphologic information compared with two-dimensional echo-
cardiography (2DE) and thie may have particular utility in cardiac valve
surgery. In order to assess the feasibility and incremental value of intraop-
erative 3D TEE, a prospective trial of intraoperative 2D and 3D TEE was
performed in 40 consecutive patients undergoing mitral and aortic valve
surgety using a multilane TEE probe and a TomTecEchoScan 3D worksta-
tion. We documented 3D acquisition and reconstruction times and compared
echocardiographic morphologic valve findings with eurgical and direct patho-
logic examination by an independent blinded obsenfer.
Results.’Mean 3D TEE acquisition time was 3.0 l 1.7 rein/acquisition,
and reconstruction time (time required to pro~ss and reconstruct clinically
acceptable 3DE images) was 10.7 + 5.0 min. Adequate 3DE imagee were
obtained in 36 (90%)of the patienta and in 85% were able to be viewed by the
surgeon before sternotomy. In 10patients (25%), 3D TEE provided additional
information that was not appreciated by 2D transthoracic and TEE and that
was confirmed by eurgery and pathology, including: 5 leaflet perforations
and 1 tear; 1 remnant and 1 broken subaotiic ridge; 2 central inadequate
AV coaptations and 1 inadequate coaptation of the medial scallop of the
PML; and 1 organized thrombus. Conclusion: In the operating room setting,
3D TEE acquisitions and reconstructions can be successfully completed in
nearly all patients in a relatively shori amount of time and can yield new
findings not appreciated by 2D transthoracic and TEE examinations.
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784-4 Quantification of Mitrsl Valve Prolspse by Three
Dimensional Echocardiogrsphy: Correlation with
Biomechsnical Cherscteristics of Excised Valve
Tissue
C.S. Breburda, 1.Vesely, A.R. Brewer, N.B. Ratliff, D.M. Coegrove, Ill,
J,D. Thomas, B.P.Griffin. The C/eve/and Clinic Foundation, C/eve/and, OH,
USA
The relationship of the biomechanical alterations (BA) to in vivo anatomical
abnormalities is not well understood in myxomatous mitral valve disease
(MVP). Method: We studied 10 pts who underwent mitral valve repair (mean
age 63 yrs, range 57–75) with intraoperative transesophageal three dimen-
sional (3D) echo (TomTec)using a multilane probe. 3D prolapse volume
(PV) and prolapse area (PA) were quantitated in 1 mm slices and compared
to uniform geometry, stiffness (a function of elasticity), failure tension and
load tensile measurements (which reflect extensibility) of the excised mitral
tissue. Results: 9 pts had a flail posterior mitral leaflet, 1 pt had severe pro-
lapse. All pts had 4 + mitral regurgitation and normal ejection fraction (mean
